The Glucose Clamp Technique In The Study of Insulin Biosimilars


The search for new insulin biosimilars is gaining in importance, especially in the face of the obesity crisis, the prevalence of type 2 diabetes, and the patent expirations of existing formulary insulins. The development and market approval of these biosimilars depends on the ability to gather accurate data concerning their effectiveness and safety—data that requires the use of the glucose clamp technique.

In this podcast, Dr. Dariush Elahi, Director of Metabolic Research, Early Phase Services, ICON plc, and Dr. Dennis Ruff, Vice President, Medical Director, Early Phase Services, ICON plc, provide an overview of glucose clamp technique.

Watch the video podcast below:

0 2008-01-18T13:10:54 Administrator

OTHER ARTICLES CATEGORISED UNDER

  • Early Phase